Trafalgar International (GCAN) Amortizatization of Intangibles (2017 - 2022)
Greater Cannabis Company (GCAN) posted quarterly Amortizatization of Intangibles of $98342.0 for Q1 2022, up 714.22% year-over-year from $12078.0 in Q1 2021, and up 39.81% quarter-over-quarter from $70339.0 in Q4 2021.
Trafalgar International (GCAN) Amortizatization of Intangibles (2017 - 2022) Analysis & Trends
Greater Cannabis Company's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $98342.0 for Q1 2022.
- In Q1 2022, Amortizatization of Intangibles rose 714.22% year-over-year to $98342.0; the TTM figure through Dec 2022 stood at $98342.0 (down 63.42% YoY), while the FY2022 annual figure was $98342.0, down 63.42% from the prior year.
- Amortizatization of Intangibles for Q1 2022 stood at $98342.0, up from $70339.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $394800.0 in Q2 2020, with the low at $4986.0 in Q4 2018.
- The 5-year median for Amortizatization of Intangibles is $68691.0 (2021), against an average of $112640.6.
- The sharpest annual moves came in 2019 and 2021: Amortizatization of Intangibles soared 5764.52% in 2019, then sank 95.93% in 2021.
- Greater Cannabis Company's Amortizatization of Intangibles stood at $4986.0 in 2018, then jumped by 5764.52% to $292405.0 in 2019, then tumbled by 50.26% to $145450.0 in 2020, then sank by 51.64% to $70339.0 in 2021, then jumped by 39.81% to $98342.0 in 2022.
- Business Quant data shows GCAN's Amortizatization of Intangibles at $98342.0 in Q1 2022, $70339.0 in Q4 2021, and $117746.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 98,342.00 |
| Mar 31, 2022 | 98,342.00 |
| Dec 31, 2021 | 70,339.00 |
| Dec 31, 2021 | 70,339.00 |
| Sep 30, 2021 | 117,746.00 |
| Sep 30, 2021 | 117,746.00 |
| Jun 30, 2021 | 68,691.00 |
| Jun 30, 2021 | 68,691.00 |
| Mar 31, 2021 | 12,078.00 |
| Mar 31, 2021 | 12,078.00 |
| Dec 31, 2020 | 145,450.00 |
| Dec 31, 2020 | 145,450.00 |
| Sep 30, 2020 | 178,280.00 |
| Sep 30, 2020 | 178,280.00 |
| Jun 30, 2020 | 394,800.00 |
| Jun 30, 2020 | 394,800.00 |
| Mar 31, 2020 | 297,073.00 |
| Mar 31, 2020 | 297,073.00 |
| Dec 31, 2019 | 292,405.00 |
| Dec 31, 2019 | 292,405.00 |